CIBC World Markets’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-21,595
Closed -$4.58M – 779
2023
Q3
$4.58M Buy
21,595
+5,896
+38% +$1.18M 0.04% 251
2023
Q2
$3.02M Buy
15,699
+13,458
+601% +$2.67M 0.02% 394
2023
Q1
$454K Buy
2,241
+33
+1% +$5.29K 0.01% 598
2022
Q4
$284K Buy
+2,208
New +$285K ﹤0.01% 660
2022
Q3
– Sell
-10,257
Closed -$1.81M – 645
2022
Q2
$1.81M Buy
10,257
+4,942
+93% +$712K 0.02% 418
2022
Q1
$766K Buy
5,315
+1,314
+33% +$178K 0.01% 555
2021
Q4
$619K Sell
4,001
-3,170
-44% -$531K ﹤0.01% 526
2021
Q3
$1.22M Sell
7,171
-22,795
-76% -$3.55M 0.01% 484
2021
Q2
$4.73M Buy
29,966
+23,034
+332% +$3.42M 0.03% 270
2021
Q1
$963K Sell
6,932
-9,187
-57% -$1.48M 0.01% 620
2020
Q4
$2.82M Buy
16,119
+6,441
+67% +$1.2M 0.01% 493
2020
Q3
$1.89M Sell
9,678
-1,518
-14% -$254K 0.02% 429
2020
Q2
$1.9M Sell
11,196
-2,969
-21% -$443K 0.02% 410
2020
Q1
$1.63M Buy
14,165
+828
+6% +$91.7K 0.02% 370
2019
Q4
$1.52M Buy
+13,337
New +$1.41M 0.01% 631

Other funds holding SGEN

CIBC World Markets's SGEN Position: Q4 2023 in Review

CIBC World Markets sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 21,595 shares — an estimated $4.58M sold.

CIBC World Markets first reported a position in SGEN in Q4 2019 and held it in 15 quarters. The position peaked at $4.73M in Q2 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • CIBC World Markets reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • CIBC World Markets sold 21,595 Seagen Inc. Common Stock shares in Q4 2023, an estimated $4.58M.
  • CIBC World Markets first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 15 quarters.
  • CIBC World Markets's Seagen Inc. Common Stock position peaked at $4.73M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on CIBC World Markets's 13F filing for Q4 2023, filed 13 Feb 2024.